CDSCO approves Syntellix implants
This opens up a huge market for the company’s Magnezis implants in India
This opens up a huge market for the company’s Magnezis implants in India
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
The trial will be conducted across eight sites in Maharashtra
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
National Institute of Animal Biotechnology, Hyderabad can now conduct quality checks and consequent lot release of Covid-19 vaccines
The product patent has been already filed under fast track approval
 
        Subscribe To Our Newsletter & Stay Updated